Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.

Ferreira VP, Cortes C, Pangburn MK.

Immunobiology. 2010 Nov;215(11):932-40. doi: 10.1016/j.imbio.2010.02.002. Epub 2010 Feb 12.

2.

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.

Stephens DS.

Vaccine. 2009 Jun 24;27 Suppl 2:B71-7. doi: 10.1016/j.vaccine.2009.04.070. Epub 2009 May 23. Review.

3.

Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates.

Schneider MC, Prosser BE, Caesar JJ, Kugelberg E, Li S, Zhang Q, Quoraishi S, Lovett JE, Deane JE, Sim RB, Roversi P, Johnson S, Tang CM, Lea SM.

Nature. 2009 Apr 16;458(7240):890-3. doi: 10.1038/nature07769. Epub 2009 Feb 18.

4.

Isolation and purification of C3 from human plasma.

O'Rear LD, Ross GD.

Curr Protoc Immunol. 2001 May;Chapter 13:Unit 13.3. doi: 10.1002/0471142735.im1303s14.

PMID:
18432716
5.

The alternative complement pathway revisited.

Harboe M, Mollnes TE.

J Cell Mol Med. 2008 Aug;12(4):1074-84. doi: 10.1111/j.1582-4934.2008.00350.x. Epub 2008 Apr 15. Review.

6.

Properdin and complement activation: a fresh perspective.

Hourcade DE.

Curr Drug Targets. 2008 Feb;9(2):158-64. Review.

PMID:
18288967
7.
8.

Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance.

Ram S, Ngampasutadol J, Cox AD, Blom AM, Lewis LA, St Michael F, Stupak J, Gulati S, Rice PA.

Infect Immun. 2007 Aug;75(8):4071-81. Epub 2007 May 25.

9.

Interactions between Neisseria meningitidis and the complement system.

Schneider MC, Exley RM, Ram S, Sim RB, Tang CM.

Trends Microbiol. 2007 May;15(5):233-40. Epub 2007 Mar 29. Review.

PMID:
17398100
10.

Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.

Madico G, Ngampasutadol J, Gulati S, Vogel U, Rice PA, Ram S.

J Immunol. 2007 Apr 1;178(7):4489-97.

11.

Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso.

Findlow H, Vogel U, Mueller JE, Curry A, Njanpop-Lafourcade BM, Claus H, Gray SJ, Yaro S, Traoré Y, Sangaré L, Nicolas P, Gessner BD, Borrow R.

J Infect Dis. 2007 Apr 1;195(7):1071-7. Epub 2007 Feb 16.

PMID:
17330799
12.

Properdin deficiency in a boy with fulminant meningococcal septic shock.

Genel F, Atlihan F, Gulez N, Sjöholm AG, Skattum L, Truedsson L.

Acta Paediatr. 2006 Nov;95(11):1498-1500.

PMID:
17062484
13.

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, Costello CE, Ngampasutadol J, Vogel U, Granoff DM, Ram S.

J Immunol. 2006 Jul 1;177(1):501-10.

14.

Functional significance of factor H binding to Neisseria meningitidis.

Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, Tang CM.

J Immunol. 2006 Jun 15;176(12):7566-75.

15.

The role of properdin in the assembly of the alternative pathway C3 convertases of complement.

Hourcade DE.

J Biol Chem. 2006 Jan 27;281(4):2128-32. Epub 2005 Nov 21.

16.
17.

Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis.

Jarva H, Ram S, Vogel U, Blom AM, Meri S.

J Immunol. 2005 May 15;174(10):6299-307.

18.

Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.

Hoang LM, Thomas E, Tyler S, Pollard AJ, Stephens G, Gustafson L, McNabb A, Pocock I, Tsang R, Tan R.

Clin Infect Dis. 2005 Mar 1;40(5):e38-42. Epub 2005 Feb 7.

PMID:
15714405
19.

The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

PILLEMER L, BLUM L, LEPOW IH, ROSS OA, TODD EW, WARDLAW AC.

Science. 1954 Aug 20;120(3112):279-85. No abstract available.

PMID:
13186838
20.

Many carried meningococci lack the genes required for capsule synthesis and transport.

Claus H, Maiden MC, Maag R, Frosch M, Vogel U.

Microbiology. 2002 Jun;148(Pt 6):1813-9.

PMID:
12055301

Supplemental Content

Support Center